Cafepharma Today

March 27 2023 - Novartis' Kisqali cuts recurrence risk in early-stage breast cancer
Novartis' Kisqali cuts recurrence risk in early-stage breast cancer
Novo's high-dose Rybelsus win tees up regulatory filings
BioNTech's COVID-19 vaccine revenue forecasts lower than expected
BrainStorm secures FDA adcomm for ALS therapy NurOwn
*please scroll down for all the latest news*

Current News

submit a press release

Click here to stay updated on CP happenings
In his first year as Johnson & Johnson CEO, Duato scored $13.1M payout
Fierce Pharma
Wednesday, March 15, 2023 - 12:03pm
tags:
Joaquin Duato, JNJ, Pharma CEOs, executive compensation
Concentra's Buy Offer May Jeopardize Jounce's Merger with Redx
BioSpace
Wednesday, March 15, 2023 - 11:29am
tags:
Jounce Therapeutics, Redx, Concerta, M&A
AbbVie's Humira, 5 Pfizer drugs among those with price hikes that exceeded inflation rate
Fierce Pharma
Wednesday, March 15, 2023 - 11:25am
tags:
Pfizer, AbbVie, Humira, drug pricing, inflation
Novartis and Pfizer-Backed Mediar Nets $85M for Fibrosis Paradigm Shift
BioSpace
Wednesday, March 15, 2023 - 11:17am
tags:
Mediar Therapeutics, Novartis, Pfizer, fibrosis
Amgen is sued for concealing $10.7 billion tax bill from investors
Reuters
Wednesday, March 15, 2023 - 11:11am
tags:
Amgen, taxes, legal, Puerto Rico
Veru Moves Forward with Late-Stage COVID Study Despite FDA Roadblock
BioSpace
Wednesday, March 15, 2023 - 10:13am
tags:
Veru, COVID-19, sabizabulin, clinical trials
Strategy Behind Lowered Insulin Prices: Novo Nordisk and Eli Lilly
BioSpace
Wednesday, March 15, 2023 - 10:06am
tags:
insulin, diabetes, drug pricing, Eli Lilly, Novo Nordisk
Further shuffling at Leo Pharma as dermatology drugmaker splits R&D
Endpoints
Wednesday, March 15, 2023 - 10:05am
tags:
LEO Pharma, R&D, dermatology
Morphic looks to justify “oral Entyvio” excitement
EP Vantage
Wednesday, March 15, 2023 - 10:04am
tags:
Morphic Therapeutics, MORF-057, ulcerative colitis
A game-changer in contraception? Male birth control study offers promising results
Medical Marketing and Media
Wednesday, March 15, 2023 - 10:02am
tags:
contraceptives, male contraceptives, male birth control pill
Exscientia builds cancer pipeline with two BMS drugs
Pharmaphorum
Wednesday, March 15, 2023 - 9:57am
tags:
Exscientia, Bristol Myers Squibb, oncology, EXS73565, EXS74539
In Pfizer-Seagen review, FTC has chance to set new pharma precedent
BioPharma Dive
Tuesday, March 14, 2023 - 6:28pm
tags:
FTC, Pfizer, Seagen, M&A, antitrust, anticompetitive practices
FDA staff report says data shows Pfizer’s Covid treatment Paxlovid is effective in high-risk adults
CNBC
Tuesday, March 14, 2023 - 6:26pm
tags:
Pfizer, Paxlovid, COVID-19, FDA, antivirals
BioSpace Salary Report: Life Sciences Salaries Grow at Slower Pace than Previous Years
BioSpace
Tuesday, March 14, 2023 - 6:24pm
tags:
life sciences, salaries, compensation
Bayer study finds communication gap in managing chronic kidney disease in patients with type 2 diabetes
Medical Marketing and Media
Tuesday, March 14, 2023 - 6:22pm
tags:
Bayer, diabetes, chronic kidney disease, healthcare providers, physicians
Chasing Pfizer, GSK's 5-in-1 meningococcal vaccine delivers phase 3 trial win
Fierce Pharma
Tuesday, March 14, 2023 - 6:21pm
tags:
vaccines, GSK, Pfizer, meningococcal disease, Menveo, Bexsero
Study sheds light on ethics of pharma-patient influencer partnerships
Medical Marketing and Media
Tuesday, March 14, 2023 - 6:19pm
tags:
social media, pharma marketing, patients
After $3.4B deal and EU withdrawal, Novartis looks to sell Xiidra
Fierce Pharma
Tuesday, March 14, 2023 - 11:30am
tags:
Novartis, Xiidra, ophthalmology
Amylyx’s ALS drug sales impress Wall Street
BioPharma Dive
Tuesday, March 14, 2023 - 11:28am
tags:
Amylyx, ALS, Relyvrio
Novo Nordisk Will Lower Insulin Prices Up To 75%, Following Eli Lilly
Forbes
Tuesday, March 14, 2023 - 11:27am
tags:
Novo Nordisk, drug pricing, insulin, diabetes, Eli Lilly

Pages

Latest CP Wire Articles

PharmaBlock Opens New R&D Facility in Pennsylvania ——Expanding Capacity to Deliver GMP Projects
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases
Klick Health launches new healthcare venture studio
Medtech earnings reports: insights from major players' Q4 results
Key compliance issues for medtech firms transitioning to data-enabled solutions
Following FDA COVID vaccine advisory panel vote, Novavax is prepared to provide a revised vaccine
First-of-its-kind Whole Lung Simulator is Helping Michigan Researchers Predict New Treatments and Vaccines for TB – A Reemerging Global Health Threat
Novartis signs agreement with UN-backed Medicines Patent Pool to license generics of its CML drug
Korean firm LG Chem buying AVEO Oncology for $566M

Latest Pharmagather Articles

Behind the GoodRx-Express Scripts Partnership: How PBMs Profit from Discount Cards in Pharmacy Benefits (rerun)
Drug Channels
Winning the Race for Patient Access: Identifying Copay Accumulator Impact
Drug Channels
Gene Drives Are Coming
In the Pipeline
Organizing Our Thoughts About Cells - Finally
In the Pipeline
Drug Channels News Roundup, March 2023: My $0.02 on Insulin Price Cuts, AbbVie vs. AFPs, Optum Expands, ASAP340B, and Hooray for Pharmacists
Drug Channels
The Right Assay With the Right Cells
In the Pipeline
Informa Connect’s Annual Life Sciences Commercial Contracts & Chargebacks Congress
Drug Channels
Peptide-Encoded Screening Libraries
In the Pipeline
It's Not All Bad News: Data Shows There's a Collaborative Future for 340B
Drug Channels

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information